PRESS RELEASE

from AlzChem Group AG (isin : DE000A0AHT46)

EQS-Adhoc: Alzchem Group AG raises EBITDA forecast into the range of EUR 80 million for fiscal year 2023 despite slightly lower sales expectation

EQS-Ad-hoc: Alzchem Group AG / Key word(s): Change in Forecast
Alzchem Group AG raises EBITDA forecast into the range of EUR 80 million for fiscal year 2023 despite slightly lower sales expectation

18-Oct-2023 / 16:23 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Alzchem Group AG is significantly raising its earnings forecast for the fiscal year 2023 despite a slightly lower sales expectation. Group EBITDA is expected to grow to approximately EUR 80 million (original forecast: up to EUR 70 million). Group sales are expected to be at or slightly below the previous year’s level of EUR 542.2 million; this is slightly below the most recent forecast.

The higher earnings forecast is based primarily on the very positive development of the high-margin specialty chemicals business. Particularly noteworthy in this respect are the products from the Human Nutrition (Creapure®) and Animal Nutrition (Creamino®) businesses, as well as the guanidine salts (nitroguanidine).

The forecasts for fiscal year 2023 made in the consolidated financial statements as of 31 December 2022 and last specified in July 2023 are therefore adjusted overall as follows:
 

  2022 Original forecast 2023 (according to last specification) Adjusted forecast 2023 Group sales EUR 542.2 million Slightly growing At previous year’s level or slightly below Adjusted EBITDA* EUR 61.4 million Up to EUR 70 million Strongly growing to approx. EUR 80 million Adjusted
EBITDA margin* 11.3% Up to 12% Noticeably growing Inventories EUR 122.4 million Stable Slightly to significantly decreasing Inventory intensity
(previously inventory ratio) 22.6% Stable Slightly to significantly decreasing Equity ratio 34.5% Noticeably growing Significantly growing * No adjustments were made.

 



End of Inside Information

18-Oct-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language:English
Company:Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone:+498621862888
Fax:+49862186502888
E-mail:ir@alzchem.com
Internet:www.alzchem.com
ISIN:DE000A2YNT30
WKN:A2YNT3
Listed:Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID:1752073

 
End of AnnouncementEQS News Service

1752073  18-Oct-2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1752073&application_name=news&site_id=symex
See all AlzChem Group AG news